QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wells-fargo-maintains-equal-weight-on-mckesson-lowers-price-target-to-535

Wells Fargo analyst Stephen Baxter maintains McKesson (NYSE:MCK) with a Equal-Weight and lowers the price target from $576 t...

 citigroup-maintains-buy-on-mckesson-lowers-price-target-to-630

Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and lowers the price target from $670 to $630.

 biologics-by-mckessons-rytelotm-fda-gets-approval-for-treatment-of-patients-with-low--to-intermediate-1-risk-myelodysplastic-syndromes--with-transfusion-dependent-anemia

Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Geron...

 leerink-partners-maintains-outperform-on-mckesson-lowers-price-target-to-665

Leerink Partners analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Outperform and lowers the price target from $67...

 mckesson-sees-q2-fiscal-2025-adj-eps-to-be-in-range-of-670-700-vs-739-est-reaffirms-fy25-adj-eps-guidance-in-range-of-3175-3255-vs-3221-est

- SEC Filing 

 mckesson-agrees-to-sell-its-canada-based-rexall-and-wellca-businesses-to-birch-hill-equity-partners-no-terms-disclosed

McKesson Canada will continue to own and operate Rexall and Well.ca until transaction close, which is subject to customary clos...

 opioid-settlement-drug-distributors-mckesson-cencora-cardinal-health-to-pay-300m-to-health-insurers

Three major U.S. drug distributors, McKesson, Cencora, and Cardinal Health, have agreed to a $300 million settlement over claim...

 mckesson-inks-definitive-deal-to-acquire-controlling-interest-in-core-ventures-for-approximately-249b-in-cash-which-will-represent-70-ownership

FCS physicians will continue to retain a minority interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core ...

 mckesson-in-talks-for-stake-in-florida-cancer-specialists-florida-cancer-specialists-stake-could-fetch-35b-mckesson-has-been-competing-with-other-bidders-for-stake---bloomberg-news

https://www.bloomberg.com/news/articles/2024-08-23/mckesson-nears-deal-for-stake-in-florida-cancer-chain?utm_content=business&a...

 jp-morgan-maintains-overweight-on-mckesson-raises-price-target-to-661

JP Morgan analyst Lisa Gill maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $656 to $661.

 warner-bros-airbnb-and-monster-beverage-are-among-top-10-large-cap-losers-last-week-aug-4-aug-10-are-the-others-in-your-portfolio

These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. be...

 barclays-maintains-overweight-on-mckesson-raises-price-target-to-616

Barclays analyst Steve Valiquette maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $596 to $...

 evercore-isi-group-maintains-outperform-on-mckesson-lowers-price-target-to-630

Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and lowers the price target fr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION